Sleep and Depression in Induction of Labour

Sponsor
Turku University Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT03380897
Collaborator
University of Turku (Other)
117
1
2
30.8
3.8

Study Details

Study Description

Brief Summary

Randomised trial comparing double balloon catheter for induction of labor between inpatient and outpatient groups. The investigators assess how sleep disturbances and depression of the mother affect to the pain during balloon catheter induction of labour.

Condition or Disease Intervention/Treatment Phase
  • Other: Intervention for outpatient group was to go home
  • Other: Intervention for inpatient group was to stay at ward
N/A

Detailed Description

Participants included to this randomised study are women with uncomplicated singleton pregnancy with ≥ 37- ≤ 41+5 weeks of gestation. Participants are randomised to two groups: one hundred are randomised to the inpatient and one hundred to the outpatient group.

The main outcome measure is the pain evaluated by VAS at one, five , nine and 13 hours after the placement of double balloon induction catheter. The investigators assess also the effect of the sleep disturbance and depression of the mother to the pain during balloon catheter induction of the labour.

The total hospital stay and induction to delivery interval time is measured. Also the mode of birth as well as maternal and neonatal morbidity and patient satisfaction are recorded.

Study Design

Study Type:
Interventional
Actual Enrollment :
117 participants
Allocation:
Randomized
Intervention Model:
Factorial Assignment
Intervention Model Description:
Factorial assignmentFactorial assignment
Masking:
None (Open Label)
Masking Description:
Open Label
Primary Purpose:
Health Services Research
Official Title:
Sleep Disturbances and Depression of the Mother Affect to the Pain During Balloon Catheter Induction of Labour
Actual Study Start Date :
Jun 7, 2017
Actual Primary Completion Date :
Dec 30, 2019
Actual Study Completion Date :
Dec 30, 2019

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Outpatient group

After insertion of induction catheter for labor, women of the outpatient group can go home and assess their pain with visual analogy scale at home. The intervention is to go home. Intervention for outpatient group was to go home.

Other: Intervention for outpatient group was to go home
Intervention for outpatient group was to go home and assess the the pain
Other Names:
  • Intervention was to assess the pain by visual analogy scale.
  • Placebo Comparator: Inpatient group

    After insertion of induction catheter for labor, women of the inpatient group assess their pain with visual analogy scale in the ward. The intervention is to stay at ward. Intervention for inpatient group was to stay at ward.

    Other: Intervention for inpatient group was to stay at ward
    Intervention for inpatient group was to stay at ward and assess the pain
    Other Names:
  • Intervention was to assess the pain by visual analogy scale.
  • Outcome Measures

    Primary Outcome Measures

    1. The pain measured by VAS [one to 14 days after induction of the labor]

      The pain measured by VAS after double balloon catheter insertion.

    Secondary Outcome Measures

    1. The affect of the sleep disturbances of the mother to the pain assessed by VAS [one to 14 days after induction of the labor]

      The affect of the sleep disturbances to the pain assessed by VAS

    2. The effect of depression of the mother to the pain assessed by VAS [one to 14 days after induction of the labor]

      The effect of depression of the mother to the pain assessed by VAS

    3. The total hospital stay in both groups [one to 14 days after induction of the labor]

      The total hospital stay in both groups

    4. The maternal and neonatal morbidity after balloon catheter induction [one to 14 days after induction of the labor]

      The maternal and neonatal morbidity after balloon catheter induction

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • uncomplicated pregnancy

    • singleton pregnancy

    • pregnancy weeks ≥ 37 - ≤ 41+5

    • the patient is living in1/2 hour away from hospital

    Exclusion Criteria:
    • patient has a disease that is effecting to the pregnancy e.g. pre-eclampsia, gestational hepatosis

    • the patient has medical treatment of diabetes

    • baby is not growing normally

    • multiple pregnancy

    • preterm rupture of membranes

    • earlier caesarean section

    • the patient is living more than 1/2 hour away from hospital

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Turku University Hospital Turku Finland 20520

    Sponsors and Collaborators

    • Turku University Hospital
    • University of Turku

    Investigators

    • Principal Investigator: Kirsi M Rinne, PhD, Turku University Hospital
    • Study Director: Päivi ML Polo, PhD, Turku University Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Kirsi Rinne, Senior Doctor, Turku University Hospital
    ClinicalTrials.gov Identifier:
    NCT03380897
    Other Study ID Numbers:
    • T146/2017
    First Posted:
    Dec 21, 2017
    Last Update Posted:
    Jun 11, 2020
    Last Verified:
    Jun 1, 2020
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Kirsi Rinne, Senior Doctor, Turku University Hospital
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jun 11, 2020